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Herpes simplex virus type 2 (HSV-2) is the predominant cause of
genital ulcer disease in humans, with a seroprevalence of 17% in the 14-
to 49-year age group in theUnited States (Xuet al., 2006). HSV-2 genital
ulcer disease contributes to theHIVpandemic, since the riskof acquiring
HIV infection increases 2- to 3-fold among individuals with HSV-2
infection (Holmberg et al., 1988;Wald and Link, 2002). Transmission to
neonates is another serious outcome of HSV-2 infection, often with
devastating consequences (Brown et al., 1991). Virus spread from
cell-to-cell and within neurons is essential for HSV-2 pathogenesis.
In this paper we evaluate the role of HSV-2 gE in mediating virus
spread. We deﬁne virus spread as follows: cell-to-cell spread involves
spread between adjacent epithelial cells or between epithelial cells
and neurons. Anterograde spread refers to spread across a synapse
from pre-synaptic to post-synaptic neurons, while retrograde spreadinvolves spread across a synapse from post-synaptic to pre-synaptic
neurons. Anterograde axonal transport refers to movement of viral
components within axons in the direction of the axon terminus, while
retrograde axonal transport involves movement of viral components
within axons in the direction of the neuron cell body. Targeting viral
components into axons refers to the movement of viral proteins from
the neuron cell body into axons.
HSV-2, like other members of the alphaherpesvirus family, ﬁrst
infects epithelial cells where it replicates and spreads from epithelial
cells to axons that innervate these structures. The viral DNA, capsid
proteins and some tegument proteins are transported to the neuron
nucleus where the viral DNA establishes latency within neurons in the
dorsal root ganglia (DRG). When viral DNA reactivates in the neuron
nucleus, viral components spread from theneuron cell bodyalongaxons
to the axon terminus and then to epithelial cells to cause recurrent
infections (Luxton et al., 2005; Smith et al., 2004).
Alphaherpesvirus genes US7, US8 and Us9 encode the envelope
proteins glycoprotein I (gI), glycoprotein E (gE) andUs9 respectively, that
mediate spread from pre-synaptic to post-synaptic neurons (anterograde
spread) of pseudorabies virus (PRV) (Babic et al., 1996; Brideau et al.,
2000; Brittle et al., 2004; Card et al., 1992; Ch'ng and Enquist, 2005;Husak
et al., 2000; Lyman et al., 2008;Whealy et al., 1993). HSV-1 gE and gI and
bovine herpes virus (BHV) type 1 and type 5 gE and Us9 are also required
for anterograde spread (Butchi et al., 2007; Chowdhury et al., 2000;
Chowdhury et al., 2002; McGraw et al., 2009; Snyder et al., 2008; Wang
et al., 2005). The mechanism by which these proteins mediate
Fig. 1.HSV-22.12gE-del124-495gfp (gE2-del) constructionandcharacterization. (A)Diagramof
2.12gE-del124-495gfp. 5' ﬂanking sequence: the white box represents sequences prior to the
ATGprotein coding start site,while theblackbox indicates theﬁrst 369 bpof the gE-2protein
coding sequence. 3' ﬂanking sequence: the black box represents 156 bp of the gE-2 protein
coding sequence prior to the stop codon, while the white box indicates the remaining 3'
ﬂanking sequences. The green ﬂuorescent protein under the control of a CMV promoter was
inserted into Us8 to replace the 1116 deleted bp. (B)Western blot of Vero cells infectedwith
gE2-del, rgE2-del or WT virus probed with antibodies to VP5, gE, gD, and Us9.
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has been demonstrated in targeting viral proteins from the neuron cell
body into the axon (Wang et al., 2005).
Interestingly, HSV-1 gE has a much greater impact on spread from
post-synaptic to pre-synaptic neurons (retrograde spread) in the
retina infection model than PRV gE (Brideau et al., 2000; Curanovic
et al., 2009; Wang et al., 2005). In embryonic rat SCG neuron cultures
in vitro, deletion of gE or gI results in a complete defect in HSV-1
spread from neurons to epithelial cells, but only a partial defect in
spread of PRV, indicating that differences exist in the functions
mediated by these alphaherpesviruses glycoproteins (Ch'ng and
Enquist, 2005; McGraw et al., 2009). Deletion of PRV Us9 results in
a profound decrease in anterograde spread from the rat retina to the
brain in vivo and spread from neurons to epithelial cells in vitro, while
Us9 appears to play a much more limited role for HSV-1 (Brideau
et al., 2000; Ch'ng and Enquist, 2005; McGraw et al., 2009).
The role of gE-1 invirus spread fromthe retina to thebrain, targetingof
viral components fromneuron cell bodies into axons and spread between
epithelial cells and neurons has been extensively evaluated; however, no
study has addressed the contribution of gE-2 (Dingwell et al., 1994;
Dingwell et al., 1995; McGraw et al., 2009; McGraw and Friedman, 2009;
Snyder et al., 2008; Wang et al., 2005). HSV-1 and HSV-2 gE share 72%
identity at the amino acid level; therefore, we hypothesized that these
proteinsmay share similar functions. To test this hypothesis, we deleted a
large region of the gE-2 gene comparable to that deleted in previous
studiesof gE-1 (Nagashunmugametal., 1998;Wanget al., 2005). ThegE-2
deletionmutantwas evaluated in neuronal cell cultures and in themouse
retina and ﬂank infection models to deﬁne the contribution of gE-2 to
virus spread.
Results
gE2-del virus does not express gE-2 but retains expression of
neighboring genes
We constructed gE2-del virus (2.12gE-del124–495gfp) in the back-
ground of a low passage clinical isolate, HSV-2 2.12 (Fig. 1A). The Us8
deletion was designed based on a previously described HSV-1 gE
mutant, NS-gEnull (Brittle et al., 2008; Nagashunmugam et al., 1998;
Wang et al., 2005). A rescue virus, rgE2-del, wasmade by restoring the
Us8 coding sequences and removing the gfp2 reporter gene.
Western blots were performed in Vero cells to verify the absence
of gE-2 and that neighboring genes were unaffected (Fig. 1B).
Antibody to VP5 capsid antigen was used as a loading control.
HSV-2 gE is expressed in cells infected with theWT and rescue viruses
but not with the gE2-del strain. Blots for HSV-2 glycoprotein D (gD)
and Us9 proteins showed comparable expression in cells infectedwith
gE2-del, rgE2-del or WT virus, indicating that the Us8 deletion did not
affect Us6 (gD) or Us9. We lack an antibody that detects HSV-2 gI;
therefore, we sequenced the gE2-del Us7 gene to verify that the gene
contains no unintended mutations (results not shown).
gE-2 is not required for intact single-step growth kinetics
Vero cells were infected at a MOI of 2 with WT, rgE2-del or gE2-del
virus and cells and supernatant ﬂuids were collected at 0, 1, 4, 8, 16 and
24 hpi (Fig. 2A). No statistically signiﬁcant differences were detected
comparingWT, rgE2-del or gE2-del at any time point (P=0.29 by 1-way
ANOVA); therefore, gE-2 is not required for growthofHSV-2 inVero cells.
Single-step growth experiments were performed in cultured
embryonic rat SCG neurons (Fig. 2B). Neurons were infected with WT,
rgE2-del or gE2-del virus using 2.5×105 PFU per well. Cells and
supernatants were collected for viral titers at 1, 4, 12 and 24 hpi. The
growth curves for the 3 viruses were similar with no signiﬁcant
differences at any time point (P=0.89 by 1-way ANOVA), indicating
that gE-2 is not required for replication in neurons.Replication of gE2-del virus in vivo
Toevaluate replication of thegE2-del virus invivo, 4×105 PFUofWT,
rgE2-del or gE2-del viruswas inoculated into the vitreousﬂuid chamber
of the eye of BALB/c mice. Retinas were titered at 4, 24, 72 or 120 hpi
(Fig. 2C). The gE2-del virus replicated in retinas based on an increase in
titers from4 to 72 hpi (Pb0.001); however, themutant strain replicated
to signiﬁcantly lower titers than WT or rgE2-del virus (Pb0.001). The
gE2-del virus also replicated to signiﬁcantly lower titers than WT virus
in the mouse vagina (Pb0.001) (Fig. 2D). The vaginal titers of the
gE2-del viruswere higher on day 2 than day 1, suggesting that the virus
replicates in vaginal tissues, although the difference between day 1 and
day 2 titers was not statistically signiﬁcant (P=0.17).
gE-2 is required for efﬁcient cell-to-cell spread in vitro
Vero cellswere infectedwithWT, rgE2-del or gE2-del virus and at 96
hpi the diameters of plaques weremeasured and the average area of 30
plaques calculated (Fig. 3). The gE2-del virus plaques were 6.5- to
6.9-fold reduced compared with rgE2-del and WT viruses, respectively
(Pb0.001 for each virus), demonstrating a cell-to-cell spread defect for
gE2-del virus.
gE-2 is required for virus spread from the eye to the brain in vivo
4×105 PFU of WT, rgE2-del or gE2-del virus was injected into the
vitreous body of eight-week old female BALB/c mice. In this model, the
neurons that are infected ﬁrst are the ganglion cell neurons at the
innermost layer of the retina. Virus then spreads to adjacent neurons
and supporting cells in the retina and travels from the cell bodies of
ganglion cell neurons into their axon ﬁbers that form the optic nerve
(targeting of viral components from neuron cell bodies into axons and
anterograde axonal transport) and then to post-synaptic neurons in the
brain (anterograde spread). Virus also spreads from the iris, ciliary body
or extraocular muscles of the orbit to parasympathetic or motor nerve
axons that innervate these structures (epithelial to axonspread), then to
Fig. 2. Single-step growth kinetics of WT, rgE2-del or gE2-del virus. (A) Vero cells. Results are the mean of 2 wells per time point. (B) Primary embryonic rat superior cervical ganglia
neurons. Results are the mean of 4 wells per time point±SEM. (C) Virus replication in retina. Results are the mean of 2 to 3 retinas per time point. (D) Virus replication in mice
vagina. n=5 mice at each time point±SEM.
271F. Wang et al. / Virology 405 (2010) 269–279the neuron nucleus (retrograde axonal transport) and to pre-synaptic
neurons in the brain (retrograde spread) (Figs. 4A and 5A) (McGraw
et al., 2009; Wang et al., 2005).
Retina infection by each of these viruses was assessed by
immunoﬂuorescence at 3 and 5 dpi (Fig. 4B). Viral antigens were
readily detected in the retinas infectedwithWT, rgE2-del or gE2-del on
both days, although somewhat less antigen was present in gE2-delFig. 3. (A) Plaque size of WT, rgE2-del or gE2-del virus in Vero cells. n=30 plaques per
virus±SEM.infected mice, particularly on day 5 pi, which is consistent with results
shown in Fig. 2C.
Optic nerves frommice inoculatedwithWTor rgE2-del virus contain
abundant viral antigens 3 and 5 dpi, suggesting that viral antigen is
transported from the ganglion neuron cell bodies into the axon ﬁbers of
these neurons (targeting of viral components from neuron cell bodies
into axons and anterograde axonal transport). In contrast, no viral
antigen was detected in the optic nerve of mice infected with gE2-del
virus at 3 or 5 dpi, supporting the hypothesis that gE-2 is necessary for
targeting viral proteins into axons and/or anterograde axonal transport
of viral proteins.
gE-2 is required for viral antigens to reach the brain by anterograde or
retrograde spread from the eye
The vitreous body was injected with 4×105 PFU of WT, rgE2-del or
gE2-del virus as in Fig. 4. Fig. 5A shows a model of virus spread in the
anterograde and retrograde directions to nuclei in the brain. Five and
8 (gE2-del virus only) dpi, brainswere removed, sectioned and stained for
HSV-2 antigens (Fig. 5B).WT and rgE2-del viral antigenswere detected in
mouse brains 5 dpi. Antigens were present in neurons reached by
anterograde spread from the retina, including the dorsal lateral geniculate
nucleus (LGN), the ventral LGN, and the superior colliculus. Antigenswere
also detected in neurons reached by retrograde spread from structures of
the eye, including the intergeniculate leaﬂet of the LGN and the Edinger–
Westphal nucleus. In contrast, mouse brains infected with gE2-del virus
had no viral antigen detected in any area of the brain at 5 and 8 dpi,
indicating a defect in one or more steps required for anterograde spread
Fig. 4. (A) Top ﬁgure:Model ofmouse eye and surrounding orbital structures. Virus is injected into the vitreous body of the eye fromwhich it infects retina ganglion cell neurons, iris, and
ciliary body. During the inoculation, the needle penetrates the extra-ocularmuscles,which often become infected. Middleﬁgure: Enlargement of the retina: The innermost neurons of the
retina are the ganglion cell neurons. Their axon ﬁbers comprise the optic nerve. Movement of virus particles from cell bodies of ganglion cell neurons into the optic nerve represents
targeting of viral components into axons and anterograde axonal transport. Bottom ﬁgure: Spread of virus from the ciliary body, iris or skeletal muscle to parasympathetic or motor nerve
axons (epithelial to axon spread) and then to the neuron cell body (retrograde axonal transport). (B) Retinas and optic nerves 3 or 5 dpi with 4×105 PFU ofWT, rgE2-del or gE2-del virus.
HSV-2 antigens are in red, axonﬁbers are in green and nuclei are in blue. The retinas are shown in sagittal section demonstrating all cell layers of the retinawith the innermost ganglion cell
layer towards the bottom of the ﬁgure. The optic nerve is also shown in sagittal section; however, the orientation of the retina is rotated clockwise 90° comparedwith the retina infection
ﬁgures. White arrowheads point to infected cells, including ganglion cell neurons at the innermost layer of the retina. Thick white arrows point to the optic nerve, and thin white arrows
point to viral antigens in the retina. Results shown are representative of 3 retinas and optic nerves evaluated forWT and rgE2-del viruses, and 6 retinas and optic nerves for gE2-del virus.
Magniﬁcation is 200× for retina infections, and 100×for optic nerves.
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anterograde axonal transport, or spread from pre-synaptic to post-
synaptic neurons) and retrograde spread (spread from iris, ciliary body or
muscles to axons, retrograde axonal transport, or spread from post-
synaptic to pre-synaptic neurons).gE-2 is required for virus spread from neurons to epithelial cells in vitro
We used the Campenot chamber system and embryonic rat SCG
neurons to assess spreadof virus fromneurons to epithelial cells (McGraw
et al., 2009). SCG neurons were added to the soma (S) chamber and
273F. Wang et al. / Virology 405 (2010) 269–279allowed to differentiate. Over 1–2 weeks, neurites grew into the middle
(M) and neurite (N) (axon) chambers. The M chamber was ﬁlled with
methylcellulose to prevent leakage of virus from one compartment to
another. Vero cells were seeded into the N chamber 1 d prior to infection
of neurons in the S chamber. The addition of Vero cells is based on
observations with PRV that indicator cells are required in the N chamber
to detect virus transported from the S to N chamber (Ch'ng and Enquist,
2005; Curanovic and Enquist, 2009). 105 PFU of WT, rgE2-del or gE2-del
viruswas added to the S chamber and at 48hpi the contents of the S andN
chambers were harvested and titers determined on Vero cells. WT,
rgE2-del, and gE2-del viruses grew to equivalent titers in the S chamber
(Fig. 6A). WT and rgE2-del viruses spread to Vero cells in the N chamber
by 48 hpi and reached titers of 3.7 log10 and 3.3 log10, respectively. In
contrast, no gE2-del virus was detected in the N-chamber (Fig. 6B)
(Pb0.001 compared with WT and rgE2-del). These results indicate that
gE2-del virushas adefect in spread inoneormoreof the following: spread
from the neuron cell body into axons, anterograde axonal transport, or
spread from axons to epithelial cells.
gE-2 targets viral proteins into axons
To further evaluate the site of the block in gE2-del virus spread, rat
SCG neurons were infected with 105 PFU of WT, rgE2-del or gE2-del
virus. The neurons were stained for envelop glycoprotein gD, capsid
protein VP26 at 18 hpi (both shown in red), and neuroﬁlaments to
outline the neuron cell bodies andmost importantly the axon ﬁlaments
(shown in green). Viral gD and VP26 antigens were detected in neuron
cell bodies and axons after infectionwithWT and rescue viruses (Fig. 7).
gE2-del gD and VP26 antigens were readily detected in neuron cell
bodies; however, no viral antigenwas detected in axons, indicating that
gE-2 is required for targeting viral proteins fromneuron cell bodies into
axons. This result is consistent with the optic nerve ﬁndings described
in Fig. 4B.
gE-2 is required for efﬁcient spread from epithelial cells to axons, but not
for retrograde axonal transport in vitro
To further assess the retrograde spread phenotype of gE2-del virus,
105 PFU ofWT, rgE2-del or gE2-del (MOI 3.3) was added to N chambers
containing 3×104 conﬂuent, polarized HaCaT cells that were seeded
1 week earlier on top of neurites. At 48 hpi the contents of the S and N
chambers were collected and titered on Vero cells. The N chamber
showed equivalent titers of the 3 viruses, indicating comparable
replication in HaCaT cells (Fig. 8A); however, S chamber titers were
signiﬁcantly different comparing the 3 viruses (Fig. 8B). WT and
rgE2-del virus titers were approximately 3 log10 higher than gE2-del
virus (Pb0.001), indicating that gE-2 is required for efﬁcient spread
from epithelial cells to axons (epithelial-to-axon spread) and/or spread
from axons to neuron cell bodies (retrograde axonal transport).
To deﬁne the site of the defect in spread, WT, rgE2-del or gE2-del
virus was added directly to the neurites in the N chamber. No HaCaT
cells were present; therefore, virus did not ﬁrst spread from epithelial
cells to neurites. Under these conditions, no difference in S chamber
titers was detected comparing the 3 viruses (Fig. 8C), suggesting that
gE-2 is required for spread from epithelial cells to axons, rather than
for retrograde axonal transport.
gE-2 is required for virus spread from epithelial cells to neurons in the
mouse ﬂank model
Nine-week-old female BALB/cmicewere infectedby scariﬁcationon
denuded ﬂank skin. In this model, the presence of zosteriform disease
indicates that virus has spread from epithelial cells to axons, traveled by
retrograde axonal transport to DRG, traveled by anterograde axonal
transport back to the axon terminus and then spread from the axon
terminus to epithelial cells (McGraw et al., 2009).Micewere infected by ﬂank scariﬁcation with 5×105 PFUWT, rgE2-
del or gE2-del virus or were mock infected and monitored for survival
(Fig. 9A), inoculation site, and zosteriform site disease (Fig. 9B–C). 100%
of animals infected with WT or rgE2-del virus died by 10 and 13 dpi,
respectively, while all animals infected with gE2-del virus survived
(Pb0.001 compared with WT or rgE2-del virus). WT and rgE2-del
viruses resulted in severe inoculation site and zosteriform site disease
that were not signiﬁcantly different from one another (P=0.89). The
gE2-del virus disease at the inoculation site was signiﬁcantly less than
WT or rgE2-del virus (Pb0.001), but not signiﬁcantly different from
mock-infected animals (P=0.87). The gE2-del virus produced no
zosteriform site disease and no infectious gE2-del virus was detected
in DRG at 1, 3, 6, or 8 dpi compared with approximately 1.5 log10 PFU of
WT virus (Fig. 9D) (P=0.02 at 6 dpi). Photographs of inoculation site
and zosteriform site disease from representativemice taken at 7 dpi are
shown(Fig. 9E). These results indicate that in the absence of gE-2,HSV-2
causes little or no disease in the mouse ﬂank model and is defective in
spread from epithelial cells to neurons in DRG.
Discussion
We used in vitro and in vivo approaches to deﬁne the spread
phenotype of an HSV-2 gE mutant strain. We modiﬁed gE-2 by
introducing a large deletion from amino acids 124–495, which was
based on our previous studies of HSV-1 gE that deleted amino acids
124–508 (Brittle et al., 2008; Nagashunmugam et al., 1998;Wang et al.,
2005). Our results suggest that gE-1 and gE-2 mediate similar spread
functions, since both gE-1 and gE-2 affect epithelial cell-to-cell spread,
epithelial-to-axon spread, spread from skin toneurons inDRG, targeting
of viral proteins from the neuron cell body into axons, and anterograde
and retrograde spread from the mouse retina to the brain (Brittle et al.,
2008; McGraw et al., 2009; McGraw and Friedman, 2009; Wang et al.,
2005). We previously reported that HSV-1 gEnull virus is a candidate
attenuated live HSV-1 vaccine. Based on comparable properties of the
gE2-del viruswe plan to evaluate this strain as anHSV-2 attenuated live
virus vaccine.
The gE2-del virus defective spread from epithelial cells to neurons is
likely the result of at least two abnormalities. First, gE2-del virus is
defective in epithelial cell-to-cell spread, as measured by small plaque
size in vitro and diminished inoculation site disease in vivo. The low
epithelial cell titers limit the quantity of virus available to infect axons.
Second, gE2-del virus is impaired in epithelial cell-to-axon (neurite)
spread based on studies in Campenot chambers. When HaCaT cells in
the N chamber were infectedwith gE2-del virus, we detected reduced S
chamber titers; however,whenneurites in theN chamberwere infected
in the absence of HaCaT cells, S chamber titers were not reduced. The
epithelial-to-epithelial and the epithelial-to-neurite spread defectsmay
both contribute to the lack of infectious gE2-del virus in DRG after ﬂank
inoculation. These same defects may also explain the absence of viral
antigens in brain nuclei reached by retrograde spread.
The gE2-del virus replicates comparable toWT and rgE2-del viruses
in SCG neurons in vitro; therefore, the spread defect from neurons to
epithelial cells in Campenot chambers cannot be explained by lack of
replication in neurons. In the retina infection model, the gE2-del virus
replicates to lower titers than WT or rgE2-del virus (5.7 log10 versus 6
log10); however, these relatively small differences are unlikely to
account for the striking absence of gE2-del antigens in the optic nerve.
Defective targeting of viral components from the neuron cell body into
axons clearly contributes to the spread defect detected in Campenot
chambers and likely accounts for the lack of gE2-del antigen in the optic
nerve, rather than a defect in anterograde axonal transport.
These studies represent an evaluation of the contributions of gE-2
to spread. HSV-2 Us9 and gI may also contribute to spread and studies
are in progress to identify the functions of these proteins. Cellular
binding partners for gE-2 have yet to be identiﬁed, which will aid in
understanding themechanisms by which gE-2 mediates epithelial-to-
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into axons. A greater understanding of these interactions could lead to
the design of inhibitors of neuroinvasion or to candidate HSV-2
vaccines.
Although the spread functions mediated by gE-1 and gE-2 are
similar, it is not knownwhether gE-1 and gE-2 contribute comparably
to immune evasion. HSV-1 gE forms a complex with gI on the virus
envelope and infected cell surface to serve as an IgG Fc receptor. An
important function of the HSV-1 Fc receptor is that it mediates
antibody bipolar bridging. This term refers to the binding of the Fab
domain of an antibodymolecule that is targeting HSV-1 antigens, such
as gD, and the binding of the Fc domain of the same antibodymolecule
to the viral Fc receptor (Frank and Friedman, 1989; Lin et al., 2004).
Antibody bipolar bridging blocks functions mediated by the Fc
domain, including complement activation and antibody dependent
cellular cytotoxicity (Dubin et al., 1991; Frank and Friedman, 1989;
Lin et al., 2004; Nagashunmugam et al., 1998).
In summary, HSV-2 is an important human pathogen that requires
spread between epithelial cells and axons and viral transport within
axons for its lifecycle in humans. Glycoprotein E of the related
alphaherpesviruses HSV-1, PRV, BHV-1, and BHV-5 contributes
signiﬁcantly to neuroinvasion by mediating virus spread. Here we
demonstrate an important role for HSV-2 gE in promoting virus
spread from epithelial cells to axons and an essential role in targeting
viral proteins from the neuron cell body into axons.
Materials and methods
Virus strains
HSV-2 strain 2.12 was isolated from a woman with genital ulcer
disease and used at passage 8 to derive the mutant strain (Hook et al.,
2006). HSV-2 WT gE contains 545 amino acids, while mutant strain
2.12gE-del(124–495gfp) (gE2-del virus) has a deletion of amino acids
124–495 that were replaced by the green ﬂuorescent protein-2 (gfp2)
cassette under the control of a CMVpromoter. To introduce the CMV-gfp2
cassette into HSV-2 strain 2.12, 5' and 3' HSV-2 ﬂanking sequences were
linked to the cassette. The 5' region contains 669 bp, including 300 bp
upstream of the protein start site and 369 bp of the gE-2 protein. The
primers used to amplify the 5’ ﬂanking region were 5'-GACGGTACCGC
CCCCATCGTG-3' and 5'-GTTAAGCTTCTTTCCTGCGTTATCCC-3'. The 3'
ﬂanking region has 541 bp, including 156 bp at the C-terminus of gE-2.
The primers used to amplify the 3' ﬂanking region were 5'-GGCCTGCA-
GACAAATGGATCCGG-3' and 5'-GTAGAGCTCCGCGGAAGGGCG-3'. The 5'
ﬂanking region was inserted into pBluescript SK+at Kpn1 and HindIII
sites and the 3' ﬂanking region at Pst1 and Sac1 sites. The gfp2 cassette
under a CMV promoter (pGFP2-N1, BioSignal Packard) was inserted
between the ﬂanking regions at the HindIII and Pst1 sites. The resulting
construct was sequenced and co-transfected with HSV-2 2.12 DNA.
Plaques were screened for green ﬂuorescence, plaque puriﬁed 3 times,
and then evaluated by Western blot for the gE-2 protein.
A rescue strain (rgE2-del) to restorewild-type (WT) gE-2 sequences
was constructed byPCRampliﬁcationofDNAencompassing300 bp 5' of
the translation start site to 385 bp 3' of the protein stop codon using the
same 5' and 3' primers as described above and inserted into pBluescriptFig. 5. (A) Theeye is shownat the bottomof theﬁgure. Spreadof viral antigens from the retina to t
body intoaxonsandanterogradeaxonal transport. Spreadof antigen to the superior colliculus (SC),
topost-synapticneurons (anterograde spread). Spreadof virus fromtheeye to theoculomotornucl
eye to the innervating axons (epithelial to axon spread), retrogradeaxonal transport and spread fro
ofmousebrains5or8dpiof the retinawith4×105PFUofWT, rgE2-delorgE2-del virus. The locatio
(requires targeting of viral antigens from the neuron cell body into axons and anterograde axonal t
virus infectedmice by 5 dpi but not in the brains ofmice infectedwith gE2-del at 5 or 8dpi. Column
(anterograde spread, ﬁlled arrowhead) and the intergeniculate leaﬂet of the LGN (retrograde spre
infectedwith gE2-del virus. Column C: HSV-2 antigen is detected in the SC (requires anterograde
withWTor rgE2-del virus but not in the brains ofmice infectedwith gE2-del virus. Results shown a
is 20×.SK+at Kpn1 and Sac1 sites that were incorporated into the construct.
Rescue plaques were screened for the absence of green ﬂuorescence,
plaque puriﬁed 3 times, and then screened for gE-2 by Western blot.
Cells and antibodies
Vero cells (African green monkey kidney epithelial cells) and HaCaT
cells (human keratinocytes) were grown in Dulbecco's modiﬁed Eagle's
medium supplemented with 10 mM HEPES (pH 7.3), 2 mM L-glutamine
(Invitrogen), 100 U/ml penicillin and 100 μg/ml streptomycin
(Invitrogen), and 10% heat-inactivated fetal bovine serum (Hyclone).
Mousemonoclonal anti-HSV-1gD(1D3)andrabbit polyclonal anti-HSV-1
VP5 (NC1), gD(R7), gE (UP575),Us9, andVP26werepreviouslydescribed
(Cohen et al., 1980; Desai et al., 2003; Friedman et al., 1984; Hook et al.,
2008; Isola et al., 1989; Lin et al., 2004; McGraw et al., 2009). Rabbit
polyclonal anti-HSV-2 (Dako), rat anti-mouse Thy 1.2 (Pharmingen),
chicken anti-neuroﬁlament heavy chain (Abcam), Alexa Fluor 555 goat
anti-mouse andanti-rabbit IgG, andAlexa Fluor 488goat anti-chicken and
donkey anti-rat IgG (Invitrogen) were purchased.
Western blotting
Vero cells were mock infected or infected with HSV-2 strain 2.12
(WT), rgE2-del, or gE2-del at a MOI of 2. The cells were lysed with cell
culture lysis buffer (Promega) containing a cocktail of protein inhibitors
(Roche) at 20 h post infection (hpi). Cell lysates were subjected to
sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis on a
4% to 15% gel, transferred to an Immobilon-P membrane, and probed
with rabbit anti-HSV-1 VP5 (1:5,000), rabbit UP575 anti-HSV-1 gE
(1:5,000), rabbit R7 anti-HSV-1 gD (1:100,000), or rabbit anti-HSV-1
Us9 (1:10,000).
Embryonic rat SCG neuronal cell cultures
DissociatedSCG fromE17Sprague–Dawley rat embryos (Charles River
Laboratories) were plated into assembled Campenot chambers to contain
approximately 5000 neurons per chamber as previously described
(McGraw and Friedman, 2009). The neurons were differentiated for
2 weeks before use. For anterograde transport studies, 3×104 Vero cells
were seeded into the neurite (N) chamber 1 day prior to infection. For
evaluation of virus spread from epithelial cells to axons, 3×104 HaCaT
cells were allowed to polarize in the N chamber for 1 week prior to
infection (McGraw and Friedman, 2009). The N or S chambers were
infected with 105 PFU of virus, and at the time points indicated, the
contents of the chambers were harvested and titered on Vero cell
monolayers.
Single-step growth curves
Vero cell monolayers were infected with HSV-2 WT, rgE2-del, or
gE2-del at a MOI of 2. An aliquot of the inoculumwas frozen at−80 °C
and served as the time0harvest. After 1 h adsorption at 37 °C, cellswere
treatedwith citrate buffer (pH 3.0) for 1 min followed by 2washeswith
PBS (pH 7.4) to remove virus that had not yet entered cells. Cells and
supernatantswere harvested immediately after the citrate wash, whichheoptic nerve andoptic tract (OT) requires targeting of viral components from theneuron cell
dorsal andventral lateral geniculatenuclei (dLGN, vLGN) represents spread frompre-synaptic
eus (OMN)andEdinger–Westphal nucleus (EWN)requires spread from infected tissues in the
mpost-synaptic topre-synaptic neurons (retrograde spread). (B) Immunoperoxidase staining
nofantigen is indicatedbydarkprecipitate. ColumnA:HSV-2antigenappears in theoptic tract
ransport, arrow) and the dLGN (requires anterograde spread, arrowhead) inWT and rgE2-del
B:HSV-2 antigen is present in the dLGN (requires anterograde spread, arrowhead), the vLGN
ad, arrow) in the brains of WT and rgE2-del virus infected mice but not in the brains of mice
spread, arrowhead), the OMN and EWN (requires retrograde spread, arrow) of mice infected
re representative of 3mouse brains evaluated for each virus at each timepoint.Magniﬁcation
275F. Wang et al. / Virology 405 (2010) 269–279wasconsidered the1 hpost infection (hpi) timepoint, and at4, 8, 16and
24 hpi, frozen, thawed once, sonicated and titered on Vero cell
monolayers (McGraw and Friedman, 2009).Approximately 5,000 neurons from half of a SCG were placed in a
12-well plate and infectedwith 2.5×105 PFU. A high titer inoculumwas
used to ensure infection of all the neurons since much of the inoculum
Fig. 6. Virus spread from neuron cell bodies along axons and to epithelial cells in
Campenot chambers. (A and B) Vero cells were added to the N chamber one day prior to
infection. 105 PFU of WT, gE2-del, or rgE2-del virus was added to the S chamber and at
48 hpi the contents of the S (A) and N (B) chambers were titered on Vero cells. The limit
of detection for the titration is 1 PFU.
Fig. 7. HSV-2 gE is required for targeting envelop and capsid proteins into axons. SCG neuron
neurons were stained with antibodies to viral antigens gD (red, ﬁrst column), VP26 (red, fo
images (third and sixth columns). White arrows indicate viral antigens in axons. Most cells
WT or rgE2-del virus and stained for VP26). Note the total absence of gD or VP26 antigen (
Fig. 8. Spread of virus from epithelial cells to neuron cell bodies in Campenot chambers. (A an
to infection with 1×105 PFU of WT, gE2-del, or rgE2-del virus. At 48 hpi, contents of the S
chamber were infected with 1×105 PFU ofWT, gE2-del, or rgE2-del virus in the absence of H
n=5 chambers for each assay±SEM.
Fig. 9. Infection of the mouse ﬂank with 5×105 PFU of WT, rgE2-del, or gE2-del virus,
(C) Zosteriform site disease scores± SEM. (D) DRG titers comparingWT and gE2-del viruses
or gE2-del virus at 7 dpi.
276 F. Wang et al. / Virology 405 (2010) 269–279remains attached to thematrix (McGrawand Friedman, 2009). After 1 h
incubation at 37 °C, virus that had not yet entered neurons was
inactivated by a citrate buffer (pH 3.0) wash. At the time points
indicated, the contents of the wells were harvested and titered on Vero
cell monolayers (McGraw and Friedman, 2009).
Plaque size analysis
Conﬂuent Vero cells were infected with 60 PFU/well of HSV-2WT,
rgE2-del, or gE2-del, and at 1 hpi overlaid with 0.6% low-melt agarose.
At 96 hpi, the diameters of 30 plaques were measured with an optical
micrometer in an inverted light microscope at 40X magniﬁcation, and
the area calculated based on the size of 2 perpendicular diameters of
each plaque (McGraw and Friedman, 2009; Weeks et al., 2000).
Eye injections and virus titers in retinas
The retinas of anesthetized eight-weekold female BALB/cmicewere
infected by inoculation of the vitreous body with 4×105 PFU of HSV-2s were infected with 105 PFU of WT, rgE2-del or gE2-del virus and at 18 h post infection,
urth column), to SCG neuroﬁlaments (green, second and ﬁfth columns), and as merged
are infected as separate neurons; however, some neurons are in clusters (infected with
red) in SCG axons infected with gE2-del virus. Magniﬁcation is 400×.
d B) HaCaT cells were seeded in the N chamber and allowed to polarize for 1 week prior
(A) and N (B) chamber were harvested and titered on Vero cells. (C) Neurites in the N
aCaT cells. At 24 hpi, contents of the S chamber were harvested and titered on Vero cells.
or mock-inoculation (A–C). (A) Survival. (B) Inoculation site disease scores±SEM.
± SEM. (E) Photographs taken of mock infectedmice ormice infected withWT, rgE2-del
277F. Wang et al. / Virology 405 (2010) 269–279
278 F. Wang et al. / Virology 405 (2010) 269–279WT, rgE2-del, or gE-del in 1 μl as previously described (McGraw et al.,
2009).Micewere anesthetized at the indicated times post infection, and
perfused by intracardiac injection with PBS. Eyes were harvested and
the lenses and corneas removed. The retinas were washed with PBS,
frozen, thawed, homogenized in PBS, sonicated, and centrifuged at
1500g at 4 °C for 5 min, and supernatants were titered on Vero cells
(Wang et al., 2005).Immunoﬂuorescence and immunohistochemistry of eye and brain tissues
Three to 8 days post infection (dpi) mice were anesthetized and
perfused by intracardiac injection with 10 ml of 4% paraformaldehyde in
0.1 M sodium phosphate buffer pH 7.4. Eyes were dissected leaving optic
nerves attached to the retinas, while brainswere separated from the optic
nerves. Eyes and brains were ﬁxed in 4% paraformaldehyde overnight at
4 °C and then placed in 30% sucrose overnight at 4 °C. Samples were
embedded in TBS freezing medium (Triangle Biomedical Sciences). Eyes
were cut into 10 μmsagittal sections onto Tissue Tack slides (Polysciences,
Inc.). Brains were cut into 40 μm coronal sections and placed in
cryoprotectant solution (30% sucrose, 1% polyvinylpyrrolidone, and 30%
ethylene glycol in 0.1 M PBS, pH 7.2) and stored at−20 °C until staining
(McGraw et al., 2009; Wang et al., 2005).
Retinaswere stainedwith a rabbit polyclonalHSV-2 antibody todetect
viral antigens and with rat anti-mouse Thy 1.2 to identify mouse axon
ﬁbers (McGraw and Friedman, 2009; Wang et al., 2005). Secondary
antibodies included Alexa 555 goat anti-rabbit IgG and Alexa 488 donkey
anti-rat IgG.Backgroundstainingwas reducedby incubating inPBSand1%
horse serum, 1% BSA, and 0.05% Triton X-100 for 30 min. Primary
antibodies (1:500) and secondary antibodies (1:200) were diluted in PBS
with 0.3% Triton X-100. The primary antibodies were incubated for 2 h
and the secondary antibodies for 1 h at room temperature. DAPI
(4'-6'-diamidino-2-phenylindole) (Molecular Probes) was added with
the secondary antibodies to stain nuclei.
Brain sections were stained by incubating with polyclonal rabbit
anti-HSV-2 antibody (1:2,000) for 36 h at room temperature, followed by
biotinylated goat anti-rabbit IgG (1:200) and avidin–biotin/peroxidase
(1:100; Vector Laboratories, Inc.) each added for 90 min at room
temperature (Wang et al., 2005). The color was developed using
diaminobenzidine (DAB) and hydrogen peroxide (Sigma), and sections
were mounted onto gelatin-coated slides.Immunoﬂuorescence of rat SCG neurons
Rat SCG neurons were harvested from E17 Sprague–Dawley rat
embryos and plated in 35 mm tissue culture dishes on a glass cover slip.
After 10 to 14 days, the SCGneuronswere infected and at 18 hpiﬁxed and
stained with primary and secondary antibodies as previously described
(Wang et al., 2005). Pictures were taken on a Nikon Eclipse E1000
microscope using Phase 3 Imaging Systems.Mouse ﬂank model
Nine-week old BALB/cmicewere ﬂank inoculatedwith 5×105 PFU of
HSV-2 WT, rgE2-del or gE2-del virus as previously described
(Nagashunmugam et al., 1998). Mice were monitored for survival and
scored for disease at the inoculation site on a scale of 0–4, where 0 is no
disease, 1 is redness or swelling, 2 is skin erosion, 3 is ulcers and 4 is
necrosis. Lesions outside the inoculation sitewere considered zosteriform
disease, whichwas scored on a 0–4 scale, where 0 is no lesions, 1 is one or
more discrete lesions, 2 is coalesced lesions, 3 is ulcerated lesions, and 4 is
necrosis (Brittle et al., 2008). DRG were harvested at the indicated times
and processed by mincing with scissors, pulverizing with a pestle, and
titering on Vero cells (Brittle et al., 2008).Mouse vaginal model
Replication of 5×105 PFU of HSV-2 WT and gE2-del viruses was
compared in the vagina of 5- to 6-week-old BALB/cmice. Mice received a
subcutaneous injection of 2 mg of medroxyprogesterone (Sicor Pharma-
ceuticals, Inc., Irvine, CA) in 0.9% NaCl and 10 mM Hepes 5 days prior to
infection (Brittle et al., 2008). Swabswereperformedat 1hpi, and1, 2, and
3 dpi and virus titers determined by plaque assay on Vero cells.
Statistics
GraphPadPrismsoftwarewasused for all statistical analyses.One-way
ANOVA with Tukey's adjustment was used for comparison of 3 or more
groups, while t tests were used for comparison of two groups. Survival
analysis was performed using the Logrank (Mantel-Cox) test.
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